Kangmei Pharmaceutical Co., Ltd. (SHA:600518)
China · Delayed Price · Currency is CNY 1.280
+0.020 (1.59%)
Oct 30, 2026, 3:00 PM CST
Kangmei Pharmaceutical Market Cap
Kangmei Pharmaceutical has a market cap or net worth of 17.7 billion as of October 30, 2026. It is the 5,438th most valuable company in the world and the 854th biggest in China. Its market cap has decreased by 36.95% in one year.
Market Cap
17.70B
Enterprise Value
16.53B
Revenue
4.82B
Global Rank
Country Rank
#854 China
PE Ratio
226.07
ChartMarket Cap Chart
Since March 19, 2001, Kangmei Pharmaceutical's market cap has increased from 2.58B to 17.70B, an increase of 586.47%. That is a compound annual growth rate of 7.80%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 17.70B | -32.98% |
| Dec 31, 2025 | 26.41B | -18.58% |
| Dec 31, 2024 | 32.44B | 25.81% |
| Dec 29, 2023 | 25.79B | -15.45% |
| Dec 30, 2022 | 30.50B | -28.80% |
| Dec 31, 2021 | 42.84B | 221.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Jilin Aodong Pharmaceutical Group | 19.74B |
| Shanghai Haoyuan Chemexpress | 19.64B |
| Hybio Pharmaceutical | 19.31B |
| Guangdong Zhongsheng Pharmaceutical | 18.72B |
| Joincare Pharmaceutical Group Industry | 18.39B |
| Walvax Biotechnology | 17.42B |
| Chengdu Kanghong Pharmaceutical Group | 17.32B |
| Betta Pharmaceuticals | 16.98B |